Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

Genotypes and allele frequencies of buried SNPs in a bovine single-nucleotide polymorphism array in Japanese Black cattle.

Sasaki S, Muraki E, Inoue Y, Suezawa R, Nikadori H, Yoshida Y, Nariai S, Hideshima R, Moriwaki S, Nakashima R, Uchiyama K, Yoshinari K, Takeda M, Kojima T.

Anim Sci J. 2019 Dec;90(12):1503-1509. doi: 10.1111/asj.13293. Epub 2019 Oct 10.

PMID:
31599477
2.

Thigh muscle MRI findings in myopathy associated with anti-mitochondrial antibody.

Minamiyama S, Ueda S, Nakashima R, Yamakado H, Sakato Y, Yamashita H, Sawamoto N, Fujimoto R, Nishino I, Urushitani M, Mimori T, Takahashi R.

Muscle Nerve. 2019 Oct 6. doi: 10.1002/mus.26731. [Epub ahead of print]

PMID:
31588577
3.

A Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy with High-Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis.

Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, Hirata S, Nojima T, Sugiyama E, Hatta K, Taguchi Y, Katayama M, Tanizawa K, Handa T, Uozumi R, Akizuki S, Murakami K, Hashimoto M, Tanaka M, Ohmura K, Mimori T.

Arthritis Rheumatol. 2019 Sep 16. doi: 10.1002/art.41105. [Epub ahead of print]

PMID:
31524333
4.

Impact of nutritional status, muscle mass and oral status on recovery of full oral intake among stroke patients receiving enteral nutrition: A retrospective cohort study.

Nishioka S, Yamasaki K, Ogawa K, Oishi K, Yano Y, Okazaki Y, Nakashima R, Kurihara M.

Nutr Diet. 2019 Sep 9. doi: 10.1111/1747-0080.12579. [Epub ahead of print]

PMID:
31499583
5.

Development of a structure determination method using a multidrug-resistance regulator protein as a framework.

Matsumoto T, Nakashima R, Yamano A, Nishino K.

Biochem Biophys Res Commun. 2019 Oct 15;518(2):402-408. doi: 10.1016/j.bbrc.2019.08.070. Epub 2019 Aug 17.

PMID:
31431261
6.

Acid-Tolerant Reversibly Switchable Green Fluorescent Protein for Super-resolution Imaging under Acidic Conditions.

Shinoda H, Lu K, Nakashima R, Wazawa T, Noguchi K, Matsuda T, Nagai T.

Cell Chem Biol. 2019 Oct 17;26(10):1469-1479.e6. doi: 10.1016/j.chembiol.2019.07.012. Epub 2019 Aug 15.

PMID:
31422907
7.

Auto-measure emphysematous parameters and pathophysiological gene expression profiles in experimental mouse models of acute and chronic obstructive pulmonary diseases.

Nakashima R, Kamei S, Nohara H, Fujikawa H, Maruta K, Kawakami T, Eto Y, Takahashi N, Suico MA, Takeo T, Nakagata N, Kai H, Shuto T.

J Pharmacol Sci. 2019 Jun;140(2):113-119. doi: 10.1016/j.jphs.2019.01.011. Epub 2019 Mar 26.

8.

Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis.

Ishigooka N, Fujii T, Abe H, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Ito H, Ohmura K, Morita S, Mimori T.

Mod Rheumatol. 2019 Jun 13:1-8. doi: 10.1080/14397595.2019.1621439. [Epub ahead of print]

PMID:
31116051
9.

Clinical significance of myositis-specific autoantibodies.

Nakashima R.

Immunol Med. 2018 Sep;41(3):103-112. doi: 10.1080/25785826.2018.1531188. Epub 2018 Nov 17.

PMID:
30938275
10.

Crystal structures of multidrug efflux pump MexB bound with high-molecular-mass compounds.

Sakurai K, Yamasaki S, Nakao K, Nishino K, Yamaguchi A, Nakashima R.

Sci Rep. 2019 Mar 13;9(1):4359. doi: 10.1038/s41598-019-40232-2.

11.

Serum matrix metalloproteinase levels in polymyositis/dermatomyositis patients with interstitial lung disease.

Nakatsuka Y, Handa T, Nakashima R, Tanizawa K, Kubo T, Murase Y, Sokai A, Ikezoe K, Hosono Y, Watanabe K, Tokuda S, Uno K, Yoshizawa A, Tsuruyama T, Uozumi R, Nagai S, Hatta K, Taguchi Y, Mishima M, Chin K, Mimori T, Hirai T.

Rheumatology (Oxford). 2019 Mar 8. pii: kez065. doi: 10.1093/rheumatology/kez065. [Epub ahead of print]

PMID:
30851107
12.

Detection of DNA damage response in nonalcoholic fatty liver disease via p53-binding protein 1 nuclear expression.

Akazawa Y, Nakashima R, Matsuda K, Okamaoto K, Hirano R, Kawasaki H, Miuma S, Miyaaki H, Malhi H, Abiru S, Itoh M, Kondo H, Fukuoka J, Nakao K, Nakashima M.

Mod Pathol. 2019 Jul;32(7):997-1007. doi: 10.1038/s41379-019-0218-8. Epub 2019 Feb 26.

PMID:
30809000
13.

Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis.

Nakabo S, Ohmura K, Akizuki S, Murakami K, Nakashima R, Hashimoto M, Yoshifuji H, Tanaka M, Mimori T.

Mod Rheumatol. 2019 Feb 21:1-5. doi: 10.1080/14397595.2019.1583819. [Epub ahead of print]

PMID:
30789095
14.

Plaque modification using a cutting balloon is more effective for stenting of heavily calcified lesion than other scoring balloons.

Matsukawa R, Kozai T, Tokutome M, Nakashima R, Nishimura R, Matsumoto S, Katsuki M, Masuda S, Meno H.

Cardiovasc Interv Ther. 2019 Oct;34(4):325-334. doi: 10.1007/s12928-019-00578-w. Epub 2019 Feb 15.

PMID:
30771163
15.

Utility of osteopontin in cerebrospinal fluid as a diagnostic marker for neuropsychiatric systemic lupus erythematosus.

Kitagori K, Yoshifuji H, Oku T, Ayaki T, Kuzuya A, Nakajima T, Akizuki S, Nakashima R, Murakami K, Ohmura K, Hirayama Y, Takahashi R, Mimori T.

Lupus. 2019 Mar;28(3):414-422. doi: 10.1177/0961203319828818. Epub 2019 Feb 11.

PMID:
30744522
16.

Crystal structure of the multidrug resistance regulator RamR complexed with bile acids.

Yamasaki S, Nakashima R, Sakurai K, Baucheron S, Giraud E, Doublet B, Cloeckaert A, Nishino K.

Sci Rep. 2019 Jan 17;9(1):177. doi: 10.1038/s41598-018-36025-8.

17.

Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.

Hozumi H, Fujisawa T, Nakashima R, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Enomoto N, Inui N, Nakamura Y, Mimori T, Suda T.

J Rheumatol. 2019 May;46(5):509-517. doi: 10.3899/jrheum.180778. Epub 2019 Jan 15.

PMID:
30647164
18.

Curcumin Down-Regulates Toll-Like Receptor-2 Gene Expression and Function in Human Cystic Fibrosis Bronchial Epithelial Cells.

Chaudhary N, Ueno-Shuto K, Ono T, Ohira Y, Watanabe K, Nasu A, Fujikawa H, Nakashima R, Takahashi N, Suico MA, Kai H, Shuto T.

Biol Pharm Bull. 2019 Mar 1;42(3):489-495. doi: 10.1248/bpb.b18-00928. Epub 2019 Jan 10.

19.

Integrative expression analysis identifies a novel interplay between CFTR and linc-SUMF1-2 that involves CF-associated gene dysregulation.

Kamei S, Maruta K, Fujikawa H, Nohara H, Ueno-Shuto K, Tasaki Y, Nakashima R, Kawakami T, Eto Y, Suico MA, Suzuki S, Gruenert DC, Li JD, Kai H, Shuto T.

Biochem Biophys Res Commun. 2019 Feb 5;509(2):521-528. doi: 10.1016/j.bbrc.2018.12.152. Epub 2018 Dec 28.

20.

Plasma redox imbalance caused by albumin oxidation promotes lung-predominant NETosis and pulmonary cancer metastasis.

Inoue M, Nakashima R, Enomoto M, Koike Y, Zhao X, Yip K, Huang SH, Waldron JN, Ikura M, Liu FF, Bratman SV.

Nat Commun. 2018 Nov 30;9(1):5116. doi: 10.1038/s41467-018-07550-x.

21.

Beyond one's body parts: Remote object movement with sense of agency involuntarily biases spatial attention.

Nakashima R.

Psychon Bull Rev. 2019 Apr;26(2):576-582. doi: 10.3758/s13423-018-1552-4.

PMID:
30484082
22.

Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.

Nishioka A, Tsunoda S, Abe T, Yoshikawa T, Takata M, Kitano M, Matsui K, Nakashima R, Hosono Y, Ohmura K, Mimori T, Sano H.

Mod Rheumatol. 2019 Sep;29(5):814-820. doi: 10.1080/14397595.2018.1548918. Epub 2019 Feb 7.

PMID:
30449228
23.

Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis.

Nakagawa S, Nakaishi M, Hashimoto M, Ito H, Yamamoto W, Nakashima R, Tanaka M, Fujii T, Omura T, Imai S, Nakagawa T, Yonezawa A, Imai H, Mimori T, Matsubara K.

PLoS One. 2018 Nov 2;13(11):e0206943. doi: 10.1371/journal.pone.0206943. eCollection 2018.

24.

Task-irrelevant spatial dividers facilitate counting and numerosity estimation.

Li Q, Nakashima R, Yokosawa K.

Sci Rep. 2018 Oct 23;8(1):15620. doi: 10.1038/s41598-018-33877-y.

25.

[Enhancement of Pesticide Peak Response in GC-MS in the Presence of Multiple Co-Existing Reference Pesticides].

Yoshimitsu M, Akutsu K, Kitagawa Y, Takatori S, Fukui N, Osakada M, Yamaguchi S, Namikawa M, Ban S, Okubo Y, Nakashima R, Maruyama R, Kakutani N, Miyamoto I, Yamashita K, Nishiyama T, Shinto M, Yamamoto N, Takai Y, Hinoshita K, Kajimura K, Obana H, Watanabe T.

Shokuhin Eiseigaku Zasshi. 2018;59(3):146-150. doi: 10.3358/shokueishi.59.146. Japanese.

26.

Anti-EJ, anti-MDA5 double-positive chronic clinically amyopathic dermatomyositis: a case report.

Takeuchi Y, Hashimoto M, Nakashima R, Tanaka M, Kuramoto N, Murakami K, Yoshifuji H, Ohmura K, Mimori T.

Rheumatol Adv Pract. 2018 Jun 23;2(2):rky022. doi: 10.1093/rap/rky022. eCollection 2018. No abstract available.

27.

[A case of anti-PL-7 antibody positive polymyositis with thrombotic microangiopathy].

Tamura M, Kitano M, Azuma K, Tsuboi K, Abe T, Ogita C, Yokoyama Y, Furukawa T, Yoshikawa T, Saito A, Nishioka A, Sekiguchi M, Azuma N, Tsunoda S, Hosono Y, Nakashima R, Ohmura K, Matsui K, Mimori T, Sano H.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):450-455. doi: 10.2177/jsci.40.450. Japanese.

28.

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovsk√Ĺ J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.

Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13.

PMID:
29331962
29.

Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition.

Zwama M, Yamasaki S, Nakashima R, Sakurai K, Nishino K, Yamaguchi A.

Nat Commun. 2018 Jan 9;9(1):124. doi: 10.1038/s41467-017-02493-1.

30.

Acid-Tolerant Monomeric GFP from Olindias formosa.

Shinoda H, Ma Y, Nakashima R, Sakurai K, Matsuda T, Nagai T.

Cell Chem Biol. 2018 Mar 15;25(3):330-338.e7. doi: 10.1016/j.chembiol.2017.12.005. Epub 2017 Dec 28.

31.

Zinc Deficiency via a Splice Switch in Zinc Importer ZIP2/SLC39A2 Causes Cystic Fibrosis-Associated MUC5AC Hypersecretion in Airway Epithelial Cells.

Kamei S, Fujikawa H, Nohara H, Ueno-Shuto K, Maruta K, Nakashima R, Kawakami T, Matsumoto C, Sakaguchi Y, Ono T, Suico MA, Boucher RC, Gruenert DC, Takeo T, Nakagata N, Li JD, Kai H, Shuto T.

EBioMedicine. 2018 Jan;27:304-316. doi: 10.1016/j.ebiom.2017.12.025. Epub 2017 Dec 20.

32.

Crystallographic Analysis of Drug and Inhibitor-Binding Structure of RND-Type Multidrug Exporter AcrB in Physiologically Relevant Asymmetric Crystals.

Nakashima R, Sakurai K, Yamaguchi A.

Methods Mol Biol. 2018;1700:25-36. doi: 10.1007/978-1-4939-7454-2_2.

PMID:
29177823
33.

Hoisting-Loop in Bacterial Multidrug Exporter AcrB Is a Highly Flexible Hinge That Enables the Large Motion of the Subdomains.

Zwama M, Hayashi K, Sakurai K, Nakashima R, Kitagawa K, Nishino K, Yamaguchi A.

Front Microbiol. 2017 Oct 25;8:2095. doi: 10.3389/fmicb.2017.02095. eCollection 2017.

34.

Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice.

Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T.

Mod Rheumatol. 2018 Jul;28(4):626-636. doi: 10.1080/14397595.2017.1380249. Epub 2017 Oct 3.

PMID:
28972439
35.

Prediction of prognosis of upper-extremity function following stroke-related paralysis using brain imaging.

Nakashima A, Moriuchi T, Mitsunaga W, Yonezawa T, Kataoka H, Nakashima R, Koizumi T, Shimizu T, Ryu N, Higashi T.

J Phys Ther Sci. 2017 Aug;29(8):1438-1443. doi: 10.1589/jpts.29.1438. Epub 2017 Aug 10.

36.

A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production.

Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T.

Arthritis Res Ther. 2017 Sep 6;19(1):197. doi: 10.1186/s13075-017-1408-8.

37.

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis.

Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C.

Sci Rep. 2017 Jul 31;7(1):6911. doi: 10.1038/s41598-017-07137-4.

38.

UCHL1-HIF-1 axis-mediated antioxidant property of cancer cells as a therapeutic target for radiosensitization.

Nakashima R, Goto Y, Koyasu S, Kobayashi M, Morinibu A, Yoshimura M, Hiraoka M, Hammond EM, Harada H.

Sci Rep. 2017 Jul 31;7(1):6879. doi: 10.1038/s41598-017-06605-1.

39.

Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.

Hozumi H, Fujisawa T, Enomoto N, Nakashima R, Enomoto Y, Suzuki Y, Kono M, Karayama M, Furuhashi K, Murakami A, Inui N, Nakamura Y, Mimori T, Suda T.

J Rheumatol. 2017 Sep;44(9):1394-1401. doi: 10.3899/jrheum.170373. Epub 2017 Jul 15.

PMID:
28711881
40.

Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.

Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K.

J Rheumatol. 2017 Sep;44(9):1384-1388. doi: 10.3899/jrheum.161432. Epub 2017 May 15.

PMID:
28507178
41.

The whereabouts of visual attention: Involuntary attentional bias toward the default gaze direction.

Nakashima R, Kumada T.

Atten Percept Psychophys. 2017 Aug;79(6):1666-1673. doi: 10.3758/s13414-017-1332-7.

PMID:
28500508
42.

The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.

Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.

Respir Med. 2017 Jun;127:57-64. doi: 10.1016/j.rmed.2017.04.007. Epub 2017 Apr 15.

43.

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.

Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K.

Rheumatology (Oxford). 2017 Jul 1;56(7):1217-1226. doi: 10.1093/rheumatology/kex088.

44.

Evaluation of calcium hydrogen carbonate mesoscopic crystals as a disinfectant for influenza A viruses.

Nakashima R, Kawamoto M, Miyazaki S, Onishi R, Furusaki K, Osaki M, Kirisawa R, Sakudo A, Onodera T.

J Vet Med Sci. 2017 May 23;79(5):939-942. doi: 10.1292/jvms.16-0603. Epub 2017 Apr 10.

45.

Structural Analysis and New Drug Development against Multidrug Efflux Pumps.

Yamasaki S, Nakashima R, Sakurai K, Yamaguchi A, Nishino K.

Yakugaku Zasshi. 2017;137(4):377-382. doi: 10.1248/yakushi.16-00235-2. Review. Japanese.

46.

Clinical Images: Chronic Nonbacterial Osteomyelitis.

Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T.

Arthritis Rheumatol. 2017 Aug;69(8):1660. doi: 10.1002/art.40108. Epub 2017 Jul 5. No abstract available.

47.

Peripersonal versus extrapersonal visual scene information for egocentric direction and position perception.

Nakashima R, Kumada T.

Q J Exp Psychol (Hove). 2018 May;71(5):1090-1099. doi: 10.1080/17470218.2017.1310267. Epub 2018 Jan 1.

PMID:
28326888
48.

Intracellular calcium release channels: an update.

Santulli G, Nakashima R, Yuan Q, Marks AR.

J Physiol. 2017 May 15;595(10):3041-3051. doi: 10.1113/JP272781. Review.

49.

Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.

Fujisawa T, Hozumi H, Kono M, Enomoto N, Nakamura Y, Inui N, Nakashima R, Imura Y, Mimori T, Suda T.

Respir Investig. 2017 Mar;55(2):130-137. doi: 10.1016/j.resinv.2016.09.006. Epub 2017 Feb 8.

PMID:
28274528
50.

Critical Care Management Focused on Optimizing Brain Function After Cardiac Arrest.

Nakashima R, Hifumi T, Kawakita K, Okazaki T, Egawa S, Inoue A, Seo R, Inagaki N, Kuroda Y.

Circ J. 2017 Mar 24;81(4):427-439. doi: 10.1253/circj.CJ-16-1006. Epub 2017 Feb 24. Review.

Supplemental Content

Loading ...
Support Center